BANK OF AMERICA CORP /DE/
BankPosition in FDMT — 4D Molecular Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,904,963
+$5,835,414 QoQ
Shares Held
1,120,674
+15.0% QoQ
Ownership
1.55%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 158 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Derivatives in FDMT
reported options exposure · as of Jun 30, 2025CallValue
$11,130
CallShares
3,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,049,938,280 across 338 Biotechnology names. FDMT ranks #96 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in FDMT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,904,963 | 1,120,674 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,069,549 | 974,173 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $6,244,431 | 832,591 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,119,420 | 819,266 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $11,130 | 3,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $3,328,128 | 897,070 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,255,533 | 698,308 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,143,779 | 384,880 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $128,217 | 11,861 | Shares | Defined | 2025-03-18 | |
| 2024-06-30 | $4,777,300 | 227,599 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $371,105 | 11,648 | Shares | Defined | 2025-03-18 | |
| 2023-12-31 | $3,350,111 | 165,356 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,750,754 | 137,530 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,852,317 | 102,508 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,315,656 | 192,883 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,719,320 | 77,412 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $160,018 | 19,903 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $153,187 | 21,947 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,632,655 | 107,980 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,918,584 | 87,447 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $340,441 | 12,623 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $265,239 | 11,015 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $298,322 | 6,877 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,658 | 40 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||